Change language dansk English suomi svenska

Generate Estimates Confirm Cancel Hide empty rows Show hidden rows DummyText

MISSIONPHARMA A/S - Group Estimate generation in progress, please wait... 0%

Quicksearch from your own companies XBRLDenmark Analyst: XBRLDenmark

Loading... Loading... Loading... Loading... Loading... Loading... Loading...

1.0 Bankruptcy Risk  2018 N/A 2019 N/A 2020 N/A 2021 2022/3 2022 2023/3 2023 2024/3 2024e N/A 2025e N/A Bankruptcy risk for industry   1.5% 1.5% 1.5% 1.5% 1.5% 1.5% 1.1% 1.1%   Bankruptcy risk   0.0% 0.0% 0.0% 0.4% 0.4% 0.4% 6.7% 6.6%   Credit score (0-100)   0 0 0 100 99 99 36 36   Credit rating   N/A N/A N/A AAA AAA AAA BBB BBB   Credit limit (mDKK)   34.2 31.8 44.5 37.3 47.6 44.4 0.0 0.0   How are these values calculated?   View the automatically generated explanation of bankruptcy risk 1.0 Income statement (mDKK)  2018 N/A 2019 N/A 2020 N/A 2021 2022/3 2022 2023/3 2023 2024/3 2024e N/A 2025e N/A Net sales   753 777 731 694 924 929 929 929   Gross profit   109 81.5 172 122 229 220 0.0 0.0   EBITDA   109 81.5 172 73.2 164 154 0.0 0.0   EBIT   109 81.5 172 71.6 160 151 0.0 0.0   Pre-tax profit (PTP)   38.6 22.2 83.6 73.7 154.4 153.9 0.0 0.0   Net earnings   38.6 22.2 83.6 58.0 119.3 119.7 0.0 0.0   Pre-tax profit without non-rec. items   109 81.5 172 73.7 154 154 0.0 0.0     See the entire income statement 1.0 Balance sheet (mDKK)  2018 N/A 2019 N/A 2020 N/A 2021 2022/3 2022 2023/3 2023 2024/3 2024e N/A 2025e N/A Tangible assets total   0.0 0.0 0.0 23.7 29.7 30.0 0.0 0.0   Shareholders equity total   270 263 332 313 351 321 201 201   Interest-bearing liabilities   0.0 0.0 0.0 0.9 0.0 4.7 0.0 0.0   Balance sheet total (assets)   391 381 427 429 550 470 201 201   Net Debt   0.0 0.0 0.0 -8.2 -25.0 -29.1 -201 -201     See the entire balance sheet 1.0 Volume  2018 N/A 2019 N/A 2020 N/A 2021 2022/3 2022 2023/3 2023 2024/3 2024e N/A 2025e N/A Net sales   753 777 731 694 924 929 929 929   Net sales growth   0.0% 3.2% -5.9% -5.1% 33.2% 0.5% 0.0% 0.0%   Gross profit   109 81.5 172 122 229 220 0.0 0.0   Gross profit growth   0.0% -25.5% 110.9% -28.9% 87.6% -4.1% -100.0% 0.0%   Employees   62 62 58 55 150 158 0 0   Employee growth %   0.0% 0.0% -6.5% -5.2% 172.7% 5.3% -100.0% 0.0%   Employee expenses   0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0   Balance sheet total (assets)   391 381 427 429 550 470 201 201   Balance sheet change%   0.0% -2.7% 12.1% 0.3% 28.4% -14.5% -57.3% 0.0%   Added value   109.4 81.5 171.9 73.2 161.2 154.3 0.0 0.0   Added value %   14.5% 10.5% 23.5% 10.6% 17.4% 16.6% 0.0% 0.0%   Investments   0 0 0 22 2 -1 -31 0   Net sales trend   0.0 1.0 -1.0 -2.0 1.0 2.0 0.0 0.0   EBIT trend   1.0 2.0 3.0 4.0 5.0 5.0 0.0 0.0   1.0 Profitability  2018 N/A 2019 N/A 2020 N/A 2021 2022/3 2022 2023/3 2023 2024/3 2024e N/A 2025e N/A EBITDA %   14.5% 10.5% 23.5% 10.6% 17.7% 16.6% 0.0% 0.0%   EBIT %   14.5% 10.5% 23.5% 10.3% 17.3% 16.3% 0.0% 0.0%   EBIT to gross profit (%)   100.0% 100.0% 100.0% 58.6% 69.6% 68.8% 0.0% 0.0%   Net Earnings %   5.1% 2.9% 11.4% 8.4% 12.9% 12.9% 0.0% 0.0%   Profit before depreciation and extraordinary items %   5.1% 2.9% 11.4% 8.6% 13.4% 13.2% 0.0% 0.0%   Pre tax profit less extraordinaries %   14.5% 10.5% 23.5% 10.6% 16.7% 16.6% 0.0% 0.0%   ROA %   27.9% 21.1% 42.5% 17.4% 33.4% 30.8% 0.0% 0.0%   ROI %   27.9% 21.1% 42.5% 20.1% 48.7% 45.4% 0.0% 0.0%   ROE %   14.3% 8.3% 28.1% 18.0% 36.0% 35.8% 0.0% 0.0%   1.0 Solidity  2018 N/A 2019 N/A 2020 N/A 2021 2022/3 2022 2023/3 2023 2024/3 2024e N/A 2025e N/A Equity ratio %   100.0% 100.0% 100.0% 79.3% 77.5% 79.4% 100.0% 100.0%   Relative indebtedness %   0.0% 0.0% 0.0% 16.7% 21.5% 16.1% 0.0% 0.0%   Relative net indebtedness %   0.0% 0.0% 0.0% 15.4% 18.8% 12.5% -21.6% -21.6%   Net int. bear. debt to EBITDA, %   0.0% 0.0% 0.0% -11.3% -15.3% -18.8% 0.0% 0.0%   Gearing %   0.0% 0.0% 0.0% 0.3% 0.0% 1.5% 0.0% 0.0%   Net interest   0 0 0 0 0 0 0 0   Financing costs %   0.0% 0.0% 0.0% 195.8% 2,129.4% 147.4% 0.0% 0.0%   1.0 Liquidity  2018 N/A 2019 N/A 2020 N/A 2021 2022/3 2022 2023/3 2023 2024/3 2024e N/A 2025e N/A Quick Ratio   0.0 0.0 0.0 4.2 4.5 4.6 0.0 0.0   Current Ratio   0.0 0.0 0.0 3.3 2.6 3.0 0.0 0.0   Cash and cash equivalent   0.0 0.0 0.0 9.1 25.0 33.8 0.0 0.0   1.0 Capital use efficiency  2018 N/A 2019 N/A 2020 N/A 2021 2022/3 2022 2023/3 2023 2024/3 2024e N/A 2025e N/A Trade debtors turnover (days)   0.0 0.0 0.0 18.8 24.6 22.7 0.0 0.0   Trade creditors turnover (days)   0.0 0.0 0.0 112.4 167.5 56.3 0.0 0.0   Current assets / Net sales %   0.0% 0.0% 0.0% 53.5% 54.3% 45.1% 21.6% 21.6%   Net working capital   0.0 0.0 0.0 257.7 309.7 278.4 0.0 0.0   Net working capital %   0.0% 0.0% 0.0% 37.1% 33.5% 30.0% 0.0% 0.0%   1.0 Employee efficiency  2018 N/A 2019 N/A 2020 N/A 2021 2022/3 2022 2023/3 2023 2024/3 2024e N/A 2025e N/A Net sales / employee   12 13 13 13 6 6 0 0   Added value / employee   2 1 3 1 1 1 0 0   Employee expenses / employee   0 0 0 0 0 0 0 0   EBITDA / employee   2 1 3 1 1 1 0 0   EBIT / employee   2 1 3 1 1 1 0 0   Net earnings / employee   1 0 1 1 1 1 0 0